A mucosal model to study microbial biofilm development and anti-biofilm therapeutics

Journal of Microbiological Methods

Volumn 92, Issue 2, 2013, Pages 201-208

  Anderson, Michele J ^a   Parks, Patrick J ^b   Peterson, Marnie L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b 3M COMPANY   (United States)

Author keywords

Bacteriology; Biofilm; Model systems; MRSA; Mucosa

Indexed keywords

CHLORHEXIDINE GLUCONATE;

ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BIOFILM; BIOLOGICAL MODEL; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFICACY; EX VIVO STUDY; FEMALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SWINE; VAGINA MUCOSA;

ANIMALS; BIOFILMS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MODELS, THEORETICAL; MUCOUS MEMBRANE; ORGAN CULTURE TECHNIQUES; SWINE;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84872291402     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2012.12.003     Document Type: Article

References (42)

1. Anderson G.G., Moreau-Marquis S., Stanton B.A., O'Toole G.A. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect. Immun. 2008, 76:1423-1433.
2. Anderson M.J., Horn M.E., Lin Y.C., Parks P.J., Peterson M.L. Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens. Am. J. Infect. Control. 2010, 38:826-831.
3. Anderson M.J., Lin Y.C., Gillman A.N., Parks P.J., Schlievert P.M., Peterson M. Alpha-toxin promotes mucosal biofilm formation by Staphylococcus aureus. Front. Cell. Infect. Microbiol. 2012, 2.
4. Bakaletz L.O. Bacterial biofilms in otitis media: evidence and relevance. Pediatr. Infect. Dis. J. 2007, 26:S17-S19.
5. Bellissimo-Rodrigues F., Bellissimo-Rodrigues W.T., Viana J.M., Teixeira G.C., Nicolini E., Auxiliadora-Martins M., Passos A.D., Martinez E.Z., Basile-Filho A., Martinez R. Effectiveness of oral rinse with chlorhexidine in preventing nosocomial respiratory tract infections among intensive care unit patients. Infect. Control Hosp. Epidemiol. 2009, 30:952-958.
6. Carsenti-Etesse H., Entenza J., Durant J., Pradier C., Mondain V., Bernard E., Dellamonica P. Efficacy of subinhibitory concentration of pefloxacin in preventing experimental Staphylococcus aureus foreign body infection in mice. Drugs Exp. Clin. Res. 1992, 18:415-422.
7. Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 2002, 165:867-903.
8. Christensen G.D., Simpson W.A., Bisno A.L., Beachey E.H. Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect. Immun. 1983, 40:407-410.
9. Christensen L.D., Moser C., Jensen P.O., Rasmussen T.B., Christophersen L., Kjelleberg S., Kumar N., Hoiby N., Givskov M., Bjarnsholt T. Impact of Pseudomonas aeruginosa quorum sensing on biofilm persistence in an in vivo intraperitoneal foreign-body infection model. Microbiology 2007, 153:2312-2320.
10. Coenye T., Nelis H.J. In vitro and in vivo model systems to study microbial biofilm formation. J. Microbiol. Methods 2010, 83:89-105.
11. Costerton J.W., Cheng K.J., Geesey G.G., Ladd T.I., Nickel J.C., Dasgupta M., Marrie T.J. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 1987, 41:435-464.
12. de Breij A., Gaddy J., van der Meer J., Koning R., Koster A., van den Broek P., Actis L., Nibbering P., Dijkshoorn L. CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response. Res. Microbiol. 2009, 160:213-218.
13. DeRiso A.J., Ladowski J.S., Dillon T.A., Justice J.W., Peterson A.C. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996, 109:1556-1561.
14. Donlan R.M. Biofilms and device-associated infections. Emerg. Infect. Dis. 2001, 7:277-281.
15. Erlandsen S.L., Kristich C.J., Dunny G.M., Wells C.L. High-resolution visualization of the microbial glycocalyx with low-voltage scanning electron microscopy: dependence on cationic dyes. J. Histochem. Cytochem. 2004, 52:1427-1435.
16. Fluckiger U., Ulrich M., Steinhuber A., Doring G., Mack D., Landmann R., Goerke C., Wolz C. Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model. Infect. Immun. 2005, 73:1811-1819.
17. Gelinas P., Goulet J. Neutralization of the activity of eight disinfectants by organic matter. J. Appl. Bacteriol. 1983, 54:243-247.
18. Gerhart T.N., Roux R.D., Hanff P.A., Horowitz G.L., Renshaw A.A., Hayes W.C. Antibiotic-loaded biodegradable bone cement for prophylaxis and treatment of experimental osteomyelitis in rats. J. Orthop. Res. 1993, 11:250-255.
19. Giebink G.S., Payne E.E., Mills E.L., Juhn S.K., Quie P.G. Experimental otitis media due to Streptococcus pneumoniae: immunopathogenic response in the chinchilla. J. Infect. Dis. 1976, 134:595-604.
20. Goldenberg RL M.E., Saleem S., Rouse D., Vermund S. Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstet. Gynecol. 2006, 107:1139-1146.
21. Hall-Stoodley L., Costerton J.W., Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2004, 2:95-108.
22. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
23. Kaufmann S.H.E., Rouse B.T., Sacks D.L. The Immune Response to Infection 2011, ASM Press, Washington, D.C.
24. Kluytmans J.A., Mouton J.W., Ijzerman E.P., Vandenbroucke-Grauls C.M., Maat A.W., Wagenvoort J.H., Verbrugh H.A. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J. Infect. Dis. 1995, 171:216-219.
25. Kluytmans J., van Belkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 1997, 10:505-520.
26. Kong R., Bhargava R. Characterization of porcine skin as a model for human skin studies using infrared spectroscopic imaging. Analyst 2011, 136:2359-2366.
27. Kristian S.A., Lauth X., Nizet V., Goetz F., Neumeister B., Peschel A., Landmann R. Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J. Infect. Dis. 2003, 188:414-423.
28. Kusahara D.M., Peterlini M.A., Pedreira M.L. Oral care with 0.12% chlorhexidine for the prevention of ventilator-associated pneumonia in critically ill children: randomised, controlled and double blind trial. Int. J. Nurs. Stud. 2012, 49(11):1354-1363.
29. Labeau S.O., Van de Vyver K., Brusselaers N., Vogelaers D., Blot S.I. Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis. Lancet Infect. Dis. 2011.
30. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339:520-532.
31. Martin R.R., Buttram V., Besch P., Kirkland J.J., Petty G.P. Nasal and vaginal Staphylococcus aureus in young women: quantitative studies. Ann. Intern. Med. 1982, 96:951-953.
32. Molteni B., D'Antuono A., Bandini P., Sintini G., Barcellona E., Agnello A., Milani M. Efficacy and tolerability of a new chlorhexidine-based vaginal gel in vaginal infections. Curr. Med. Res. Opin. 2004, 20:849-853.
33. Oliveira J.C., Alves F.R., Uzeda M., Rocas I.N., Siqueira J.F. Influence of serum and necrotic soft tissue on the antimicrobial effects of intracanal medicaments. Braz. Dent. J. 2010, 21:295-300.
34. Otto M. Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 2008, 322:207-228.
35. Squier C.A., Mantz M.J., Schlievert P.M., Davis C.C. Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J. Pharm. Sci. 2008, 97:9-21.
36. Stewart P.S., Costerton J.W. Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358:135-138.
37. Subbiahdoss G., Fernandez I.C., Domingues J.F., Kuijer R., van der Mei H.C., Busscher H.J. In vitro interactions between bacteria, osteoblast-like cells and macrophages in the pathogenesis of biomaterial-associated infections. PLoS One 2011, 6:e24827.
38. Thompson I.O., van der Bijl P., van Wyk C.W., van Eyk A.D. A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium. Arch. Oral Biol. 2001, 46:1091-1098.
39. Ulphani J.S., Rupp M.E. Model of Staphylococcus aureus central venous catheter-associated infection in rats. Lab. Anim. Sci. 1999, 49:283-287.
40. Wilson C.M., Gray G., Read J.S., Mwatha A., Lala S., Johnson S., Violari A., Sibiya P.M., Fleming T.R., Koonce A., Vermund S.H., McIntyre J. Tolerance and safety of different concentrations of chlorhexidine for peripartum vaginal and infant washes: HIVNET 025. J. Acquir. Immune Defic. Syndr. 2004, 35:138-143.
41. Wolcott R.D., Rhoads D.D., Dowd S.E. Biofilms and chronic wound inflammation. J. Wound Care. 2008, 17:333-341.
42. Zaga-Clavellina V., Garcia-Lopez G., Flores-Herrera H., Espejel-Nunez A., Flores-Pliego A., Soriano-Becerril D., Maida-Claros R., Merchant-Larios H., Vadillo-Ortega F. In vitro secretion profiles of interleukin (IL)-1beta, IL-6, IL-8, IL-10, and TNF alpha after selective infection with Escherichia coli in human fetal membranes. Reprod. Biol. Endocrinol. 2007, 5:46.